造血干细胞-话题@MedSci

#造血干细胞#

227篇内容 | 7872人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1271555, encodeId=cfb812e155599, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=J Clin Oncol：纳索普利单抗治疗造血干细胞移植相关血栓性微血管病的效果和安全性, objectType=article, longId=724762, objectId=4a8ee24762f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a8ee24762f1, replyNumber=0, likeNumber=95, createdTime=2022-04-23, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a8ee24762f1, moduleTitle=J Clin Oncol：纳索普利单抗治疗造血干细胞移植相关血栓性微血管病的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a8ee24762f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271554, encodeId=ee1412e1554ef, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Ann Hematol：肠道微生物群评分可以预测异基因造血干细胞移植后的存活率, objectType=article, longId=302218, objectId=ae0e302218d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae0e302218d3, replyNumber=0, likeNumber=101, createdTime=2022-04-03, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae0e302218d3, moduleTitle=Ann Hematol：肠道微生物群评分可以预测异基因造血干细胞移植后的存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae0e302218d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271553, encodeId=704a12e155377, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Ann Hematol：造血干细胞移植患者的固定剂量给药和药代动力学指导调整白消安剂量具有更高的功效、安全性和成本效益, objectType=article, longId=295383, objectId=932c295383ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=932c295383ba, replyNumber=0, likeNumber=90, createdTime=2022-02-11, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=932c295383ba, moduleTitle=Ann Hematol：造血干细胞移植患者的固定剂量给药和药代动力学指导调整白消安剂量具有更高的功效、安全性和成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=932c295383ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271552, encodeId=58cd12e1552b9, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=专题笔谈 | 重型再生障碍性贫血患者造血干细胞移植的临床研究进展, objectType=article, longId=294647, objectId=780929464e83, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=780929464e83, replyNumber=0, likeNumber=105, createdTime=2022-01-26, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=780929464e83, moduleTitle=专题笔谈 | 重型再生障碍性贫血患者造血干细胞移植的临床研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=780929464e83)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271551, encodeId=0bbe12e15517f, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=腺病毒感染与移植：造血干细胞移植(HSCT)和实体器官移植(SOT)人群感染情况, objectType=article, longId=221732, objectId=df63221e32a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df63221e32a5, replyNumber=0, likeNumber=95, createdTime=2021-12-10, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df63221e32a5, moduleTitle=腺病毒感染与移植：造血干细胞移植(HSCT)和实体器官移植(SOT)人群感染情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df63221e32a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271550, encodeId=260c12e1550dd, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=NEJM：自体造血干细胞基因疗法治疗黏多糖贮积症I型患儿, objectType=article, longId=220585, objectId=cabc22058510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cabc22058510, replyNumber=0, likeNumber=87, createdTime=2021-11-20, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cabc22058510, moduleTitle=NEJM：自体造血干细胞基因疗法治疗黏多糖贮积症I型患儿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cabc22058510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271549, encodeId=9aad12e154965, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=BJH：BNT162b2 mRNA COVID-19 疫苗在造血干细胞移植受者中的免疫原性和安全性, objectType=article, longId=219688, objectId=4a3621968844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a3621968844, replyNumber=0, likeNumber=70, createdTime=2021-11-04, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a3621968844, moduleTitle=BJH：BNT162b2 mRNA COVID-19 疫苗在造血干细胞移植受者中的免疫原性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a3621968844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271548, encodeId=0ca912e154880, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Kidney Int：小儿异基因造血干细胞移植后十年内患慢性肾脏疾病的情况, objectType=article, longId=218733, objectId=c0bf218e33a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0bf218e33a7, replyNumber=0, likeNumber=97, createdTime=2021-10-18, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0bf218e33a7, moduleTitle=Kidney Int：小儿异基因造血干细胞移植后十年内患慢性肾脏疾病的情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0bf218e33a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271547, encodeId=ae6c12e154741, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Support Care Cancer：冷冻疗法预防接受造血干细胞移植的儿童的口腔粘膜炎 , objectType=article, longId=216905, objectId=d77e216905f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d77e216905f1, replyNumber=0, likeNumber=89, createdTime=2021-09-11, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d77e216905f1, moduleTitle=Support Care Cancer：冷冻疗法预防接受造血干细胞移植的儿童的口腔粘膜炎 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d77e216905f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271546, encodeId=0fde12e154663, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=EClinicalMed：与恶性血液病患者造血干细胞移植后的结果相关的新遗传变异位点！, objectType=article, longId=216577, objectId=ae862165e771, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae862165e771, replyNumber=0, likeNumber=78, createdTime=2021-09-03, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae862165e771, moduleTitle=EClinicalMed：与恶性血液病患者造血干细胞移植后的结果相关的新遗传变异位点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae862165e771)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271545, encodeId=a4b312e1545ce, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Diabetologia：非诺贝特新作用：通过增加循环造血干细胞延缓糖尿病视网膜病变进展, objectType=article, longId=216298, objectId=7d9521629888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d9521629888, replyNumber=0, likeNumber=77, createdTime=2021-08-27, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d9521629888, moduleTitle=Diabetologia：非诺贝特新作用：通过增加循环造血干细胞延缓糖尿病视网膜病变进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d9521629888)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271544, encodeId=2c3e12e1544dc, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Int J Cancer：聚普瑞锌可有效预防接受造血干细胞移植的患者化疗相关的口腔黏膜炎, objectType=article, longId=216098, objectId=20d7216098c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20d7216098c8, replyNumber=0, likeNumber=89, createdTime=2021-08-22, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20d7216098c8, moduleTitle=Int J Cancer：聚普瑞锌可有效预防接受造血干细胞移植的患者化疗相关的口腔黏膜炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20d7216098c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271543, encodeId=d1e812e1543fc, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Leukemia：供体来源的NK细胞可降低异基因造血干细胞移植后癌症患者的复发率, objectType=article, longId=215446, objectId=0330215446c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0330215446c7, replyNumber=0, likeNumber=78, createdTime=2021-08-09, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0330215446c7, moduleTitle=Leukemia：供体来源的NK细胞可降低异基因造血干细胞移植后癌症患者的复发率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0330215446c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271542, encodeId=83bb12e154240, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Neurology-自体造血干细胞移植，治疗多发性硬化，疗效和风险共存, objectType=article, longId=214363, objectId=32b921436368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b921436368, replyNumber=0, likeNumber=91, createdTime=2021-07-19, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b921436368, moduleTitle=Neurology-自体造血干细胞移植，治疗多发性硬化，疗效和风险共存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32b921436368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271541, encodeId=a88c12e1541ee, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Neurology：自体造血干细胞移植，可有效改善多发性硬化预后, objectType=article, longId=211734, objectId=1686211e3437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1686211e3437, replyNumber=0, likeNumber=98, createdTime=2021-05-25, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1686211e3437, moduleTitle=Neurology：自体造血干细胞移植，可有效改善多发性硬化预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1686211e3437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271540, encodeId=208e12e154033, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Bone Marrow Transplant：供体源性抗CD19的CAR-T细胞疗法可安全有效的治疗异体造血干细胞移植后复发的B-ALL, objectType=article, longId=210740, objectId=e5eb210e403b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5eb210e403b, replyNumber=0, likeNumber=56, createdTime=2021-05-03, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5eb210e403b, moduleTitle=Bone Marrow Transplant：供体源性抗CD19的CAR-T细胞疗法可安全有效的治疗异体造血干细胞移植后复发的B-ALL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5eb210e403b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271539, encodeId=e56612e153941, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Clin Lymphoma Myeloma Leuk：CAR-T疗法可用于治疗异体造血干细胞移植后复发/难治的B细胞急淋白血病患者, objectType=article, longId=210737, objectId=56f3210e371b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56f3210e371b, replyNumber=0, likeNumber=98, createdTime=2021-05-03, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56f3210e371b, moduleTitle=Clin Lymphoma Myeloma Leuk：CAR-T疗法可用于治疗异体造血干细胞移植后复发/难治的B细胞急淋白血病患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56f3210e371b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271538, encodeId=877c12e153828, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：晚发型Krabbe病患儿接受造血干细胞移植治疗的长期神经发育结局, objectType=article, longId=209720, objectId=f3a6209e20c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3a6209e20c4, replyNumber=0, likeNumber=84, createdTime=2021-04-10, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3a6209e20c4, moduleTitle=Blood：晚发型Krabbe病患儿接受造血干细胞移植治疗的长期神经发育结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3a6209e20c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271537, encodeId=6ad412e1537c2, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Lancet Haematol：3期| 套细胞淋巴瘤自体造血干细胞移植后采用来那度胺维持治疗, objectType=article, longId=206002, objectId=eebf206002c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eebf206002c2, replyNumber=0, likeNumber=88, createdTime=2021-01-23, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eebf206002c2, moduleTitle=Lancet Haematol：3期| 套细胞淋巴瘤自体造血干细胞移植后采用来那度胺维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eebf206002c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271536, encodeId=3c3812e1536f5, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=NEJM：老药新用——西格列汀可降低造血干细胞移植后急性移植物抗宿主病风险, objectType=article, longId=205704, objectId=a4c6205e0425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4c6205e0425, replyNumber=0, likeNumber=108, createdTime=2021-01-15, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4c6205e0425, moduleTitle=NEJM：老药新用——西格列汀可降低造血干细胞移植后急性移植物抗宿主病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4c6205e0425)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

造血干细胞

2020-05-29发表于上海

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

J Clin Oncol：纳索普利单抗治疗造血干细胞移植相关血栓性微血管病的效果和安全性

2022-04-23

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Ann Hematol：肠道微生物群评分可以预测异基因造血干细胞移植后的存活率

2022-04-03

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Ann Hematol：造血干细胞移植患者的固定剂量给药和药代动力学指导调整白消安剂量具有更高的功效、安全性和成本效益

2022-02-11

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

专题笔谈 | 重型再生障碍性贫血患者造血干细胞移植的临床研究进展

2022-01-26

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

腺病毒感染与移植：造血干细胞移植(HSCT)和实体器官移植(SOT)人群感染情况

2021-12-10

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

NEJM：自体造血干细胞基因疗法治疗黏多糖贮积症I型患儿

2021-11-20

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

BJH：BNT162b2 mRNA COVID-19 疫苗在造血干细胞移植受者中的免疫原性和安全性

2021-11-04

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Kidney Int：小儿异基因造血干细胞移植后十年内患慢性肾脏疾病的情况

2021-10-18

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Support Care Cancer：冷冻疗法预防接受造血干细胞移植的儿童的口腔粘膜炎

2021-09-11

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

EClinicalMed：与恶性血液病患者造血干细胞移植后的结果相关的新遗传变异位点！

2021-09-03

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Diabetologia：非诺贝特新作用：通过增加循环造血干细胞延缓糖尿病视网膜病变进展

2021-08-27

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Int J Cancer：聚普瑞锌可有效预防接受造血干细胞移植的患者化疗相关的口腔黏膜炎

2021-08-22

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Leukemia：供体来源的NK细胞可降低异基因造血干细胞移植后癌症患者的复发率

2021-08-09

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Neurology-自体造血干细胞移植，治疗多发性硬化，疗效和风险共存

2021-07-19

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Neurology：自体造血干细胞移植，可有效改善多发性硬化预后

2021-05-25

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Bone Marrow Transplant：供体源性抗CD19的CAR-T细胞疗法可安全有效的治疗异体造血干细胞移植后复发的B-ALL

2021-05-03

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Clin Lymphoma Myeloma Leuk：CAR-T疗法可用于治疗异体造血干细胞移植后复发/难治的B细胞急淋白血病患者

2021-05-03

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：晚发型Krabbe病患儿接受造血干细胞移植治疗的长期神经发育结局

2021-04-10

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Lancet Haematol：3期| 套细胞淋巴瘤自体造血干细胞移植后采用来那度胺维持治疗

2021-01-23

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

NEJM：老药新用——西格列汀可降低造血干细胞移植后急性移植物抗宿主病风险

2021-01-15

科室
- - 订阅+
  - 更多科室
工具
服务